Sunday, 21 Jun 2020 08:30 AM MYT
WASHINGTON, June 21 — The US National Institutes of Health said yesterday it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalised Covid-19 patients. Earlier this week, the World Health Organisation said testing of hydroxychloroquine in its large multi-country trial of treatments for Covid-19 patients had been halted after new data and studies showed no benefit.
Trump had promoted the drug as a potential treatment, saying in March it could turn out to be “one of the biggest game changers in the history of medicine” when used in combination with the antibiotic azithromycin.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: